Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,255 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $622.53 | 5 | $0 (2020) |
| GlaxoSmithKline, LLC. | $374.54 | 3 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $258.06 | 5 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $125.00 | 1 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2019 | $125.00 | 1 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2017 | $1,005 | 11 | GlaxoSmithKline, LLC. ($374.54) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/13/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2017 | GlaxoSmithKline, LLC. | INCRUSE (Drug) | Food and Beverage | In-kind items and services | $126.99 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), DULERA | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2017 | GlaxoSmithKline, LLC. | INCRUSE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 03/30/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $118.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/23/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $4.01 | General |
| Category: RESPIRATORY | ||||||
| 03/15/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 03/15/2017 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $122.55 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $129.29 | General |
| Category: Respiratory | ||||||
| 02/27/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $121.56 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 13 | 20 | $4,000 | $1,757 |
| 2020 | 3 | 103 | 243 | $39,800 | $14,146 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 13 | 20 | $4,000 | $1,757 | 43.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 44 | 120 | $18,000 | $7,962 | 44.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 41 | 95 | $19,000 | $5,048 | 26.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 18 | 28 | $2,800 | $1,136 | 40.6% |
About Dr. Thomas Tupper, MD
Dr. Thomas Tupper, MD is a Internal Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720147879.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Tupper, MD has received a total of $1,255 in payments from pharmaceutical and medical device companies, with $125.00 received in 2020. These payments were reported across 13 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($1,255).
As a Medicare-enrolled provider, Tupper has provided services to 116 Medicare beneficiaries, totaling 263 services with total Medicare billing of $15,903. Data is available for 2 years (2020–2021), covering 4 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location New York, NY
- Active Since 12/06/2006
- Last Updated 03/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720147879
Products in Payments
- FARXIGA (Drug) $368.24
- BEVESPI AEROSPHERE (Drug) $254.29
- INCRUSE (Drug) $251.99
- BELSOMRA (Drug) $250.37
- ANORO ELLIPTA (Drug) $122.55
- ASMANEX (Drug) $7.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New York
Dr. Stephen Saletan, M.d, M.D
Internal Medicine — Payments: $2.7M
Michael Schuster, Md, MD
Internal Medicine — Payments: $2.1M
Dr. Ziad Ali, Md Dphil, MD DPHIL
Internal Medicine — Payments: $1.7M
Dr. James Underberg, Md, MD
Internal Medicine — Payments: $1.5M
Dr. Ricky Hsu, Md, MD
Internal Medicine — Payments: $1.2M
Gail Roboz, Md, MD
Internal Medicine — Payments: $1.1M